The SAFE pathway for cardioprotection: is this a promising target? (original) (raw)

References

1. Balakumar P, Singh M (2006) Anti-tumour necrosis factor-alpha therapy in heart failure: future directions. Basic Clin Pharmacol Toxicol 99:391–397. https://doi.org/10.1111/j.1742-7843.2006.pto_508.x
   Article CAS PubMed Google Scholar
2. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135. https://doi.org/10.1161/CIRCRESAHA.107.164699
   Article CAS PubMed Google Scholar
3. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008) The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120:172–185. https://doi.org/10.1016/j.pharmthera.2008.08.002
   Article CAS PubMed Google Scholar
4. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105:771–785. https://doi.org/10.1007/s00395-010-0124-1
   Article CAS PubMed PubMed Central Google Scholar
5. Boengler K, Ungefug E, Heusch G, Schulz R (2013) The STAT3 inhibitor static impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Pharm Des 19:6890–6895. https://doi.org/10.2174/138161281939131127115940
   Article CAS PubMed Google Scholar
6. Brulhart-Meynet MC, Braunersreuther V, Brinck J, Montecucco F, Prost JC, Thomas A, Galan K, Pelli G, Pedretti S, Vuilleumier N, Mach F, Lecour S, James RW, Frias MA (2015) Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS ONE 10:e0119664. https://doi.org/10.1371/journal.pone.0119664
   Article PubMed PubMed Central Google Scholar
7. Deuchar GA, Opie LH, Lecour S (2007) TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning. Life Sci 80:1686–1691. https://doi.org/10.1016/j.lfs.2007.01.040
   Article CAS PubMed Google Scholar
8. Downey JM, Cohen MV (1997) Signal transduction in ischemic preconditioning. Adv Exp Med Biol 430:39–55. https://doi.org/10.1007/978-1-4615-5959-7_4
   Article CAS PubMed Google Scholar
9. Downey JM, Davis AM, Cohen MV (2007) Signaling pathways in ischemic preconditioning. Heart Fail Rev 12:181–188. https://doi.org/10.1007/s10741-007-9025-2
   Article CAS PubMed Google Scholar
10. Frias MA, Lecour S, James RW, Pedretti S (2012) High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: role of STAT3 as part of the SAFE pathway. JAKSTAT 1:92–100. https://doi.org/10.4161/jkst.19754
    PubMed PubMed Central Google Scholar
11. Frias MA, Pedretti S, Hacking D, Somers S, Lacerda L, Opie LH, James RW, Lecour S (2013) HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis 228:110–116. https://doi.org/10.1016/j.atherosclerosis.2013.02.003
    Article CAS PubMed Google Scholar
12. Gedik N, Kottenberg E, Thielmann M, Frey UH, Jakob H, Peters J, Heusch G, Kleinbongard P (2017) Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization. Sci Rep 7:12660. https://doi.org/10.1038/s41598-017-12833-2
    Article PubMed PubMed Central Google Scholar
13. Gent S, Skyschally A, Kleinbongard P, Heusch G (2017) lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. Am J Physiol Heart Circ Physiol 312:H478–H484. https://doi.org/10.1152/ajpheart.00749.2016
    Article PubMed Google Scholar
14. Gough DJ, Koetz L, Levy DE (2013) The MEK–ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and Ras-mediated transformation. PLoS ONE 8:e83395. https://doi.org/10.1371/journal.pone.0083395
    Article PubMed PubMed Central Google Scholar
15. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD (2009) Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 119:1386–1397. https://doi.org/10.1161/CIRCULATIONAHA.108.802918
    Article CAS PubMed PubMed Central Google Scholar
16. Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol 111:70. https://doi.org/10.1007/s00395-016-0588-8
    Article PubMed PubMed Central Google Scholar
17. Hausenloy DJ, Duchen MR, Yellon DM (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury. Cardiovasc Res 60:617–625. https://doi.org/10.1016/j.cardiores.2003.09.025
    Article CAS PubMed Google Scholar
18. Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14:893–907. https://doi.org/10.1089/ars.2010.3360
    Article CAS PubMed Google Scholar
19. Heusch G, Musiolik J, Gedik N, Skyschally A (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109:1302–1308. https://doi.org/10.1161/CIRCRESAHA.111.255604
    Article CAS PubMed Google Scholar
20. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 110:111–115. https://doi.org/10.1161/CIRCRESAHA.111.259556
    Article CAS PubMed Google Scholar
21. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600. https://doi.org/10.1016/j.cell.2006.12.036
    Article CAS PubMed Google Scholar
22. Hilfiker-Kleiner D, Shukla P, Klein G, Schaefer A, Stapel B, Hoch M, Muller W, Scherr M, Theilmeier G, Ernst M, Hilfiker A, Drexler H (2010) Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 122:145–155. https://doi.org/10.1161/CIRCULATIONAHA.109.933127
    Article CAS PubMed Google Scholar
23. Hu H, Nan J, Sun Y, Zhu D, Xiao C, Wang Y, Zhu L, Wu Y, Zhao J, Wu R, Chen J, Yu H, Hu X, Zhu W, Wang J (2017) Electron leak from NDUFA13 within mitochondrial complex I attenuates ischemia–reperfusion injury via dimerized STAT3. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1704723114
    Google Scholar
24. Kalakech H, Hibert P, Prunier-Mirebeau D, Tamareille S, Letournel F, Macchi L, Pinet F, Furber A, Prunier F (2014) RISK and SAFE signaling pathway involvement in apolipoprotein A–I-induced cardioprotection. PLoS ONE 9:e107950. https://doi.org/10.1371/journal.pone.0107950
    Article PubMed PubMed Central Google Scholar
25. Karliner JS (2013) Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress. Biochim Biophys Acta 1831:203–212. https://doi.org/10.1016/j.bbalip.2012.06.006
    Article CAS PubMed Google Scholar
26. Kelly RF, Lamont KT, Somers S, Hacking D, Lacerda L, Thomas P, Opie LH, Lecour S (2010) Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res Cardiol 105:763–770. https://doi.org/10.1007/s00395-010-0125-0
    Article CAS PubMed Google Scholar
27. Kleinbongard P, Skyschally A, Gent S, Pesch M, Heusch G (2018) STAT3 as a common signal of ischemic conditioning: a lesson on “rigor and reproducibility” in preclinical studies on cardioprotection. Basic Res Cardiol 113:3. https://doi.org/10.1007/s00395-017-0660-z
    Article Google Scholar
28. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G (2014) Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 147:376–382. https://doi.org/10.1016/j.jtcvs.2013.01.005
    Article CAS PubMed Google Scholar
29. Kwan JC, Gao L, Macdonald PS, Hicks M (2015) Cardio-protective signalling by glyceryl trinitrate and cariporide in a model of donor heart preservation. Heart Lung Circ 24:306–318. https://doi.org/10.1016/j.hlc.2014.10.001
    Article PubMed Google Scholar
30. Lacerda L, Jacobs M, Opie L, Lecour S (2011) Ischaemic postconditioning confers protection via TNF: identifying the cellular origin of TNF. Eur Heart J 32:662. https://doi.org/10.1093/eurheartj/ehr324
    Google Scholar
31. Lacerda L, McCarthy J, Mungly SF, Lynn EG, Sack MN, Opie LH, Lecour S (2010) TNFalpha protects cardiac mitochondria independently of its cell surface receptors. Basic Res Cardiol 105:751–762. https://doi.org/10.1007/s00395-010-0113-4
    Article CAS PubMed PubMed Central Google Scholar
32. Lacerda L, Somers S, Opie LH, Lecour S (2009) Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84:201–208. https://doi.org/10.1093/cvr/cvp274
    Article CAS PubMed Google Scholar
33. Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S (2011) Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection. J Pineal Res 50:374–380. https://doi.org/10.1111/j.1600-079X.2010.00853.x
    Article CAS PubMed Google Scholar
34. Lecour S (2009) Activation of the protective survivor activating factor enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47:32–40. https://doi.org/10.1016/j.yjmcc.2009.03.019
    Article CAS PubMed Google Scholar
35. Lecour S, James RW (2011) When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J 32:680–685. https://doi.org/10.1093/eurheartj/ehq484
    Article CAS PubMed Google Scholar
36. Lecour S, Minners J, Rochette L, Opie LH, Sack MN (1999) Tumor necrosis factor alpha confers cardiac preconditioning—possible role of mitochondrial KATP channel mediated event. Circulation 100:S768. https://doi.org/10.1161/01.CIR.100.18.s768
    Article Google Scholar
37. Lecour S, Rochette L, Opie L (2005) Free radicals trigger TNF alpha-induced cardioprotection. Cardiovasc Res 65:239–243. https://doi.org/10.1016/j.cardiores.2004.10.003
    Article CAS PubMed Google Scholar
38. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN (2002) Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 34:509–518. https://doi.org/10.1006/jmcc.2002.1533
    Article CAS PubMed Google Scholar
39. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH (2005) Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 112:3911–3918. https://doi.org/10.1161/CIRCULATIONAHA.105.581058
    Article CAS PubMed Google Scholar
40. Meier JA, Hyun M, Cantwell M, Raza A, Mertens C, Raje V, Sisler J, Tracy E, Torres-Odio S, Gispert S, Shaw PE, Baumann H, Bandyopadhyay D, Takabe K, Larner AC (2017) Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production. Sci Signal. https://doi.org/10.1126/scisignal.aag2588
    PubMed PubMed Central Google Scholar
41. Muller J, Gorressen S, Grandoch M, Feldmann K, Kretschmer I, Lehr S, Ding Z, Schmitt JP, Schrader J, Garbers C, Heusch G, Kelm M, Scheller J, Fischer JW (2014) Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction. Basic Res Cardiol 109:440. https://doi.org/10.1007/s00395-014-0440-y
    Article PubMed Google Scholar
42. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136. https://doi.org/10.1161/01.CIR.74.5.1124
    Article CAS PubMed Google Scholar
43. Nan J, Hu H, Sun Y, Zhu L, Wang Y, Zhong Z, Zhao J, Zhang N, Wang Y, Wang Y, Ye J, Zhang L, Hu X, Zhu W, Wang J (2017) TNFR2 stimulation promotes mitochondrial fusion via Stat3- and NF-kB-dependent activation of OPA1 expression. Circ Res 121:392–410. https://doi.org/10.1161/CIRCRESAHA.117.311143
    Article CAS PubMed PubMed Central Google Scholar
44. Nduhirabandi F, Lamont K, Albertyn Z, Opie LH, Lecour S (2016) Role of toll-like receptor 4 in melatonin-induced cardioprotection. J Pineal Res 60:39–47. https://doi.org/10.1111/jpi.12286
    Article CAS PubMed Google Scholar
45. O’Sullivan KE, Breen EP, Gallagher HC, Buggy DJ, Hurley JP (2016) Understanding STAT3 signaling in cardiac ischemia. Basic Res Cardiol 111:27. https://doi.org/10.1007/s00395-016-0543-8
    Article PubMed Google Scholar
46. Pedretti S, Frias M, James R, Lecour S (2014) The cardioprotective effect of exogenous sphingosine-1-phosphate requires the activation of endogenous sphingosine-1-phosphate via the sphingosine kinase 1. Cardiovasc Res 103:S119. https://doi.org/10.1093/cvr/cvu098
    Article Google Scholar
47. Penna C, Perrelli MG, Tullio F, Angotti C, Camporeale A, Poli V, Pagliaro P (2013) Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. Basic Res Cardiol 108:371. https://doi.org/10.1007/s00395-013-0371-z
    Article CAS PubMed Google Scholar
48. Penna C, Settanni F, Tullio F, Trovato L, Pagliaro P, Alloatti G, Ghigo E, Granata R (2013) GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology 154:1624–1635. https://doi.org/10.1210/en.2012-2064
    Article CAS PubMed Google Scholar
49. Sarzi-Puttini P, Atzeni F, Shoenfeld Y, Ferraccioli G (2005) TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Autoimmun Rev 4:153–161. https://doi.org/10.1016/j.autrev.2004.09.004
    Article CAS PubMed Google Scholar
50. Schulman D, Latchman DS, Yellon DM (2002) Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol 283:H1481–H1488. https://doi.org/10.1152/ajpheart.01089.2001
    Article CAS PubMed Google Scholar
51. Schulz R, Heusch G (2009) Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction? Circulation 119:1355–1357. https://doi.org/10.1161/CIRCULATIONAHA.108.846105
    Article PubMed Google Scholar
52. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G (2015) Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways. Circ Res 117:279–288. https://doi.org/10.1161/CIRCRESAHA.117.306878
    Article CAS PubMed Google Scholar
53. Smith RM, Lecour S, Sack MN (2002) Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program. Cardiovasc Res 55:474–482. https://doi.org/10.1016/S0008-6363(02)00288-2
    Article CAS PubMed Google Scholar
54. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S (2012) Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 26:227–237. https://doi.org/10.1007/s10557-012-6376-2
    Article CAS PubMed Google Scholar
55. Suleman N, Somers S, Smith R, Opie LH, Lecour SC (2008) Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 79:127–133. https://doi.org/10.1093/cvr/cvn067
    Article CAS PubMed Google Scholar
56. Szczepanek K, Chen Q, Derecka M, Salloum FN, Zhang Q, Szelag M, Cichy J, Kukreja RC, Dulak J, Lesnefsky EJ, Larner AC (2011) Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem 286:29610–29620. https://doi.org/10.1074/jbc.M111.226209
    Article CAS PubMed PubMed Central Google Scholar
57. Szczepanek K, Xu A, Hu Y, Thompson J, He J, Larner AC, Salloum FN, Chen Q, Lesnefsky EJ (2015) Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury. Basic Res Cardiol 110:53. https://doi.org/10.1007/s00395-015-0509-2
    Article PubMed Google Scholar
58. Tanno M, Gorog DA, Bellahcene M, Cao X, Quinlan RA, Marber MS (2003) Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. J Mol Cell Cardiol 35:1523–1527. https://doi.org/10.1016/j.yjmcc.2003.09.019
    Article CAS PubMed Google Scholar
59. Watson AJ, Gao L, Sun L, Tsun J, Jabbour A, Ru Qiu M, Jansz PC, Hicks M, Macdonald PS (2013) Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution. J Heart Lung Transplant 32:633–640. https://doi.org/10.1016/j.healun.2013.03.014
    Article PubMed Google Scholar
60. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793–797. https://doi.org/10.1126/science.1164551
    Article CAS PubMed PubMed Central Google Scholar
61. Wu Q, Wang T, Chen S, Zhou Q, Li H, Hu N, Feng Y, Dong N, Yao S, Xia Z (2017) Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial. Eur Heart J. https://doi.org/10.1093/eurheartj/ehx030
    Google Scholar
62. Yu L, Li B, Zhang M, Jin Z, Duan W, Zhao G, Yang Y, Liu Z, Chen W, Wang S, Yang J, Yi D, Liu J, Yu S (2016) Melatonin reduces PERK–eIF2alpha–ATF4-mediated endoplasmic reticulum stress during myocardial ischemia–reperfusion injury: role of RISK and SAFE pathways interaction. Apoptosis 21:809–824. https://doi.org/10.1007/s10495-016-1246-1
    Article CAS PubMed Google Scholar
63. Zhao Y, Zheng ZN, Pi YN, Liang X, Jin SQ (2017) Cardioprotective effects of transfusion of late-phase preconditioned plasma may be induced by activating the reperfusion injury salvage kinase pathway but not the survivor activating factor enhancement pathway in rats. Oxid Med Cell Longev 2017:8526561. https://doi.org/10.1155/2017/8526561
    PubMed PubMed Central Google Scholar

Download references